MedTrace Logo

Social Integration During Psychiatric Inpatient Therapy as Predictor of Treatment Response

NCT04770038 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2023-03-08

No results posted yet for this study

Summary

The present longitudinal study aims at (i) identifying neurobiological mechanisms associated with successful social integration during the treatment of inpatients with Borderline Personality Disorder (BPD) and (ii) improving biomarker-based predictions of treatment response by incorporating core metrics of social integration.

Conditions

  • Borderline Personality Disorder (BPD)

Interventions

BEHAVIORAL

Dialectical Behavior Therapy (DBT)

Evidence-based psychotherapy for the treatment of Borderline Personality Disorder

Sponsors & Collaborators

  • Prof. René Hurlemann

    collaborator UNKNOWN

  • Jella Voelter, M.Sc.

    collaborator UNKNOWN

  • University of Oldenburg

    lead OTHER

Principal Investigators

  • Dirk Scheele, Prof. · Ruhr University of Bochum, Germany

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-10
Primary Completion
2023-01-21
Completion
2023-01-21

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04770038 on ClinicalTrials.gov